Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
McKesson
Express Scripts
Johnson and Johnson
Dow
Merck

Last Updated: January 24, 2020

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

AMPHETAMINE ASPARTATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Shire ADDERALL XR 10 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021303 NDA AUTHORIZED GENERIC Barr Laboratories Inc. 0555-0787-02 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0555-0787-02)
Shire ADDERALL XR 10 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021303 NDA AUTHORIZED GENERIC Barr Laboratories Inc. 0555-0788-02 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0555-0788-02)
Shire ADDERALL XR 10 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021303 NDA AUTHORIZED GENERIC Barr Laboratories Inc. 0555-0789-02 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0555-0789-02)
Shire ADDERALL XR 10 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021303 NDA AUTHORIZED GENERIC Barr Laboratories Inc. 0555-0790-02 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0555-0790-02)
Shire ADDERALL XR 10 amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate CAPSULE, EXTENDED RELEASE;ORAL 021303 NDA AUTHORIZED GENERIC Barr Laboratories Inc. 0555-0791-02 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (0555-0791-02)
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Baxter
Harvard Business School
Johnson and Johnson
Medtronic
Boehringer Ingelheim